CareRx Enterprise Value Over E B I T D A from 2010 to 2024
| CRRX Stock | CAD 1.88 0.05 2.73% |
Enterprise Value Over EBITDA | First Reported 2010-12-31 | Previous Quarter 7.43046935 | Current Value 7.8 | Quarterly Volatility 102.4291489 |
Check CareRx Corp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CareRx Corp's main balance sheet or income statement drivers, such as Interest Expense of 10.5 M, Selling General Administrative of 28.8 M or Other Operating Expenses of 381.7 M, as well as many indicators such as Price To Sales Ratio of 0.24, Dividend Yield of 0.0 or PTB Ratio of 1.08. CareRx financial statements analysis is a perfect complement when working with CareRx Corp Valuation or Volatility modules.
CareRx | Enterprise Value Over E B I T D A |
Other Information on Investing in CareRx Stock
CareRx Corp financial ratios help investors to determine whether CareRx Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CareRx with respect to the benefits of owning CareRx Corp security.